News

Is your smartphone congress-ready?

Is your smartphone congress-ready?

As of this week, the iPhone App Store and Android Market feature the EAU Congress app, so don’t forget to download it! The congress is a highly dynamic event, so having all the info about the sessions and the...
Paris Welcomes the 27th Annual EAU Congress

Paris Welcomes the 27th Annual EAU Congress

Come February, the EAU Annual Congress will return to Paris for the third time in its history. Known as the “City of Light”, the French capital has long been a global centre. Its multiculturalism, Belle Epoque splendour and historical...
Dr. Alberto Briganti joins EAU Scientific Congress Office

Dr. Alberto Briganti joins EAU Scientific Congress Office

Dr. Briganti, based at the Vita-Salute San Raffaele University Hospital, Milan (IT) was recently invited to join the EAU Scientific Congress Office. The office, chaired by Prof. Freddie Hamdy (UK) determines the scientific programme for the annual EAU Congress....
Free registration for the EAU Congress in Paris?

Free registration for the EAU Congress in Paris?

Since 2006 members of the EU-ACME programme have been able to earn continuing medical education (CME) credits by answering multiple choice questions (MCQs) that are included in all accredited articles of the EAU journals, namely: European Urology, EU Supplements...
Guidelines Office at the EAU Annual Congress

Guidelines Office at the EAU Annual Congress

The session with Axel Merseburger drew great interest, and we think, very much endorsed the principle of assembling an ad hoc panel to look at an important topic from the unbiased and neutral position of assessing published evidence using...
26th Annual EAU Congress: 2nd prize Best Abstract in Oncology

26th Annual EAU Congress: 2nd prize Best Abstract in Oncology

T. S. O`Brien and colleagues (London, UK) won the second prize for Best Abstract in Oncology during the 26th Annual EAU Congress held recently in Vienna, Austria. Below is the winning abstract, unedited and without additional commentary: Title: A...
Docetaxel as a vital option for corticosteroid-refractory prostate cancer

Docetaxel as a vital option for corticosteroid-refractory prostate cancer

The efficacy of docetaxel (TAX) chemotherapy for corticosteroid-refractory refractory prostate cancer (CRPC) is uncertain. H. Kume and colleagues conducted a study to investigate docetaxel as an option in treating corticosteroid-refractory prostate cancer. They published their findings in an online...
Late Breaking News: A preview

Late Breaking News: A preview

One of the final sessions of the congress will host three speakers presenting the very latest developments in their research. The Late Breaking News presentations, part of the fourth plenary session, will provide real “scoops” for attending urologists. All...